The use of apolipoprotein B in risk assessment

被引：0
|
作者：
不详
机构：
来源：
FUTURE CARDIOLOGY | 2006年 / 2卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：252 / 252
页数：1
相关论文
共 50 条
  • [31] Lipoprotein(a) and risk-weighted apolipoprotein B: a novel metric for atherogenic risk
    Rehman, Michaela B.
    Tudrej, Benoit V.
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [32] POSTMENOPAUSAL ESTROGEN USE AND ITS ASSOCIATION WITH APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B-100
    BOWLIN, SJ
    NAFZIGER, AN
    HOHENSEE, TE
    PEARSON, TA
    CIRCULATION, 1993, 87 (02) : 684 - 684
  • [33] Apolipoprotein B modifies the association between lipoprotein(a) and ASCVD risk
    Lai, Yuhui
    Zhang, Shaozhao
    Guo, Yue
    Xu, Chaoguang
    Huang, Mengting
    Zhan, Rongjian
    Liu, Menghui
    Xiong, Zhenyu
    Huang, Yiquan
    Liao, Xinxue
    Ma, Yuedong
    Zhuang, Xiaodong
    Jiang, Jingzhou
    Wu, Xing
    AMERICAN HEART JOURNAL, 2025, 281 : 157 - 167
  • [34] A fresh look to residual risk: triglycerides, apolipoprotein B, and sweeteners
    Crea, Filippo
    EUROPEAN HEART JOURNAL, 2024, 45 (27) : 2347 - 2351
  • [35] How, when, and why to use apolipoprotein B in clinical practice
    Sniderman, AD
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (8A): : 48I - 54I
  • [36] Measurement of rabbit apolipoprotein B by use of electroimmunodiffusion and immunonephelometric assays
    Tailleux, A
    Labbe, J
    Mallet, C
    Percevault, F
    Fruchart, JC
    Fievet, C
    COMPARATIVE MEDICINE, 2000, 50 (03) : 309 - 313
  • [37] RADIOIMMUNOASSAY OF APOLIPOPROTEIN-B WITH USE OF MONOCLONAL-ANTIBODIES
    MAYNARD, Y
    RODEN, DC
    TIKKANEN, MJ
    SCHONFELD, G
    LADENSON, JH
    CLINICAL CHEMISTRY, 1984, 30 (10) : 1620 - 1624
  • [38] MEASUREMENT OF APOLIPOPROTEIN-B AND APOLIPOPROTEIN-A BY RADIAL IMMUNODIFFUSION - METHODOLOGICAL ASSESSMENT AND CLINICAL-APPLICATIONS
    CANO, MD
    GONZALVO, C
    SCHEEN, AJ
    CASTILLO, MJ
    ANNALES DE BIOLOGIE CLINIQUE, 1994, 52 (09) : 657 - 661
  • [39] Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment
    Carr, Stuart S.
    Hooper, Amanda J.
    Sullivan, David R.
    Burnett, John R.
    PATHOLOGY, 2019, 51 (02) : 148 - 154
  • [40] Plasma apolipoprotein-B is an important risk factor for cardiovascular disease, and its assessment should be routine clinical practice
    Trompet, Stella
    Packard, Chris J.
    Jukema, J. Wouter
    CURRENT OPINION IN LIPIDOLOGY, 2018, 29 (01) : 51 - 52
12345